
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Haystack MRDTM by Quest Diagnostics is a tumor-informed, next-generation minimal residual disease (MRD) test that detects ultralow levels of circulating tumor DNA (ctDNA) to uncover residual disease after cancer treatment. Based on more than 20 years of clinical development and technology from pioneers in cancer genomics at Johns Hopkins University, Haystack MRDs purpose-built, high-precision science delivers novel insights that can help inform treatment decision-making
Haystack mrdtm by quest diagnostics operates in the Biotechnology research industry.
Haystack mrdtm by quest diagnostics's revenue is 11m - 100m
Haystack mrdtm by quest diagnostics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.